BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34055487)

  • 21. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
    Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
    Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
    Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
    Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
    Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
    Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
    Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.
    Zhao Y; Lu C; Zhu R; Hu X
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2280527. PubMed ID: 37968923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of a three-microRNA panel in serum for prostate cancer screening.
    Lin S; Sun C; Li R; Lu C; Li X; Wen Z; Ge Z; Chen W; Li Y; Li H; Lai Y
    Int J Biol Markers; 2024 Mar; 39(1):70-79. PubMed ID: 37960876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression profile of serum-related exosomal miRNAs from parathyroid tumor.
    Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B
    Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
    Huang Z; Zhu D; Wu L; He M; Zhou X; Zhang L; Zhang H; Wang W; Zhu J; Cheng W; Chen Y; Fan Y; Qi L; Yin Y; Zhu W; Shu Y; Liu P
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):188-196. PubMed ID: 27756776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
    Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
    Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients.
    Zhang L; Shan X; Wang J; Zhu J; Huang Z; Zhang H; Zhou X; Cheng W; Shu Y; Zhu W; Liu P
    Oncotarget; 2017 Oct; 8(49):86897-86907. PubMed ID: 29156844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.
    Lu C; Lin S; Wen Z; Sun C; Ge Z; Chen W; Li Y; Zhang P; Wu Y; Wang W; Chen S; Zhou H; Li X; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Wu X; Lai Y
    Biomarkers; 2024 May; ():1-9. PubMed ID: 38767408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y; Zhang Y; Yin Y; Li S
    Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A three-miRNA panel in serum as a noninvasive biomarker for colorectal cancer detection.
    Peng X; Wang J; Zhang C; Liu K; Zhao L; Chen X; Huang G; Lai Y
    Int J Biol Markers; 2020 Sep; 35(3):74-82. PubMed ID: 32914665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis.
    Li R; Chen X; Li X; Huang G; Lu C; Wen Z; Chen Z; Lai Y
    Am J Transl Res; 2022; 14(7):4606-4616. PubMed ID: 35958461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.